Lung mass evaluation

Lung Mass Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Causes
Differentiating Lung Mass from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Diagnosis
Diagnostic Study of Choice
Evaluation of Lung Mass
Imaging of Lung Mass
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Lung mass evaluation On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lung mass evaluation All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lung mass evaluation
CDC on Lung mass evaluation
Lung mass evaluation in the news
Blogs on Lung mass evaluation
Directions to Hospitals Treating bone or soft tissue mass
Risk calculators and risk factors for Lung mass evaluation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

A hallmark feature in the evaluation of lung mass is the malignancy assessment. The evaluation approach of lung mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, calcification pattern, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of lung mass. Lung mass can be divided into 2 categories: benign pulmonary mass and malignant lung mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.

Lung Mass Evaluation

• The algorithm below summarizes the initial lung mass evaluation according to imaging features.

Lung Mass Detected

Step 1: Assess likelihood of cancer ❑ Request enhanced CT scan

Step 2: What are the imaging features?

Hyperdense pulmonary mass ❑ Internal calcification

Cavitating pulmonary mass ❑ Gas-filled area ❑ Thick wall (must be greater than 2-5 mm)

Other diagnostic studies ❑ Sputum cytology ❑ Endobronchial ultrasound ❑ Endoscopic ultrasound ❑ Bronchoscopy ❑ Mediastinoscopy ❑ PET/CT

Biopsy

{{Family tree | | | | | | K01 | | | | | | |!| | | |!| | K02 | | | K03 |K01= Surgical excision/Chemo depending upon histopathology|K02=

Lung opacity on Chest X ray (CXR)

Size >3 cms; classified as lung mass

Size <3 cms; classified as pulmonary nodule

High resolution chest CT scan

Check previous CXR

Imaging features

Previous CXR normal; suggesting new growth

Previous CXR shows opacity but stable in size since then

Hyperdense pulmonary mass ❑ Internal calcification

Cavitating pulmonary mass ❑ Gas-filled area ❑ Thick wall (must be greater than 2-5 mm)

Follow up every 2-3 yrs

Other diagnostic studies ❑ Sputum cytology ❑ Endobronchial ultrasound ❑ Endoscopic ultrasound ❑ Bronchoscopy ❑ Mediastinoscopy

High resolution chest CT scan

Highly suspicious for malignancy •Age> 60yrs •Current smoker •Size >2cms ()

Suspicious for malignancy •Age 40-60yrs •Current smoker •Size 0.8-2cms

Benign features •Age <40yrs •Non smoker •Size <0.8cm

PET or biopsy

Serial CT scans

PET with biopsy

Malignancy

Not evidence of malignancy

•